Elevate Your Health with
Sermorelin
/Glycine
We're giving our favorite peptide
a power boost!
GET STARTED
Prescribed via Digital Physician Visit If Medically Appropriate
Unlock the Power of Peptides:
Boost Health, Energy,
and HGH Production with Sermorelin & Glycine
and HGH Production with Sermorelin & Glycine
We have combined our favorite synthetic peptide with a protein-building amino acid to create a new compound that may help support health, metabolism, and energy. Sermorelin, an analog of the growth hormone-releasing hormone (GHRH), and glycine, a naturally occurring amino acid, have joined forces in a rapid dissolve tablet (RDT) that may boost your HGH production, promote collagen formation, and boost your energy levels.
Our compound combines sermorelin’s growth hormone-releasing hormone (GHRH) potential properties with glycine’s potential to protect your cells against free radicals.
How this combo works
This dynamic duo comes in RDT form and combines our most popular peptide that stimulates human growth hormone and glycine, one of the most stable, naturally occurring amino acids. Combining these two potent components may promote certain anti-aging, energy boosting, and general wellness benefits.
Sermorelin/Glycine potential benefits
Aside from sermorelin's many potential benefits, when used in tandem with glycine, this powerful combo can have the following additional benefits:
May promote creatine synthesis in the body.
May have a calming effect on the brain.
Supports blood flow and healthy blood pressure through nitric oxide.
Aids glutathione production, helping defend against oxidative damage.
No injections required.
Easy to store.
Safety Info & References
Possible Side Effects
Everyone can have a different response to supplements and peptides, but the side effects from Sermorelin and Glycine are usually minimal. They can include things like nausea, flushing, headache, drowsiness, upset stomach and soft stools.
Talk to your physician for additional information or concerns.
Reference
1. Sermorelin: A better approach to management of adult-onset growth hormone insufficiency?